Effects of the administration of angiotensin II on cardiac glycogen metabolism in the rat
โ Scribed by V. Tata; A. Roso; Z. Gori; E. Bergamini
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 677 KB
- Volume
- 416
- Category
- Article
- ISSN
- 0031-6768
No coin nor oath required. For personal study only.
โฆ Synopsis
Changes in glycogen metabolism after an intravenous injection of angiotensin II were investigated in the left and right ventricles of the rat heart, as a function of location within the ventricular wall. Hearts were cut into 100-Arm thin sections, all of which were analysed for glycogen content, glucose incorporation into glycogen and 2deoxyglucose uptake and phosphorylation after the intravenous injection of ~4C-labelled sugar. In control hearts, glycogen levels were uniform across the wall in both ventricles, while the rate of sugar uptake and phosphorylation, and that of glucose incorporation into glycogen, were significantly higher in the subendocardial myocardium of the left ventricular wall. After angiotensin II administration, heart glycogen levels decreased slightly in the left, but not in the right ventricle, while 2-deoxyglucose uptake and phosphorylation, and glucose incorporation into glycogen, increased 2,5-and 5-fold, respectively. With regard to the distribution across the wall of the left ventricle after angiotensin administration, glycogen levels and glucose incorporation into glycogen were uniformly distributed, whereas sugar phosphorylation was still higher in the subendocardium.
๐ SIMILAR VOLUMES
Striatal dopamine and its metabolites were studied in rats given lithium chloride in the diet. Results showed an increase in homovanillic acid and 3,4-dihydroxyphenylacetic acid levels but no significant change in dopamine concentration after 3 weeks of lithium administration. There was no change in
## Background: Normalization of proteinuria and even regression of glomerulosclerosis seem to occur in progressive renal disease upon blockade of the renin-angiotensin system. here we quantified the effect of a combination of an angiotensin converting enzyme (ace) inhibitor and an angiotensin ii (a